跳至主要内容
临床试验/NCT02011659
NCT02011659Unknown3 期

A Randomized Prospective Study of Scheduled Intravenous Ramosetron for the Prevention of Nausea and Vomiting in Hospitalized Patients After Gynecologic Laparoscopy

National Health Insurance Service Ilsan Hospital1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2013年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
128
试验地点
1
主要终点
Incidence or intensity of PONV

研究概览

简要总结

To compare postoperative nausea and vomiting (PONV) and perioperative outcomes of gynecologic patients undergoing laparoscopic surgery after scheduled administration of intravenous Ramosetron during hospital stays.

  • Randomized controlled arm : Placebo versus Ramosetron injection
  • Administration schedule : immediate postoperative status, 12 hrs after surgery, 36hrs after surgery

详细描述

Surgical outcomes including operative time, blood loss, Hb change, postoperative pain, nausea/vomiting scale, times of rescue therapy, and complications

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age: 18< or =, = or <70 with benign gynecologic disease
  • ASA-Class I-II
  • No-definite malignancy by US, CT/MRI, CA 125 < 500IU/ml
  • Non-smoker

排除标准

  • Conversion to laparotomy
  • Hx of malignancy
  • Suspicious malignancy

研究组 & 干预措施

Ramosetron

Active Comparator

干预措施: Ramosetron (Drug)

结局指标

主要结局

Incidence or intensity of PONV

时间窗: during postoperative hospital stays (2 days)

次要结局

  • Adverse reaction associated with Ramosetron injection(Postoperatvie 7 days (at OPD based))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

San-Hui Lee

Clinical assistant professor

National Health Insurance Service Ilsan Hospital

研究点 (1)

Loading locations...

相似试验